Pharmacodynamic Effects of Sucroferric Oxyhydroxide and Sevelamer Carbonate on Vitamin D Receptor Agonist Bioactivity in Dialysis Patients

Publisher： Karger

E-ISSN： 1421-9670|44|2|104-112

ISSN： 0250-8095

Source： American Journal of Nephrology, Vol.44, Iss.2, 2016-07, pp. : 104-112

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Sevelamer Is Cost-Saving vs. Calcium Carbonate in Non-Dialysis-Dependent CKD Patients in Italy: A Patient-Level Cost-Effectiveness Analysis of the INDEPENDENT Study

By  

Blood Purification, Vol. 37, Iss. 4, 2014-08 ,pp. : 316-324

Karger

Access to resources Recommend Favorite

Vitamin D Receptor Gene Polymorphism Detected by Digestion with Apa I Influences the Parathyroid Response to Extracellular Calcium in Japanese Chronic Dialysis Patients

By  

Nephron, Vol. 89, Iss. 3, 2001-10 ,pp. : 315-320

Karger

Access to resources Recommend Favorite

Blood Pressure Is Correlated with Vitamin D3 Serum Levels in Dialysis Patients

By  

Blood Purification, Vol. 20, Iss. 4, 2002-08 ,pp. : 370-375

Karger

Access to resources Recommend Favorite

Predialysis Vitamin D Receptor Activator Treatment and Cardiovascular Events after Dialysis Initiation: A Multicenter Observational Study

By  

Nephron, Vol. 133, Iss. 1, 2016-04 ,pp. : 35-43

Karger

Access to resources Recommend Favorite

Vitamin D Receptor Gene Polymorphism and Diabetes mellitus Prevalence in Hemodialysis Patients

By  

Nephron, Vol. 84, Iss. 2, 2000-01 ,pp. : 186-186

Karger

Access to resources Recommend Favorite